(PLMR) Palomar Holdings - Overview
Stock: Earthquake, Hurricane, Flood, Marine, Crop
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -8.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | 10.43 |
| Character TTM | |
|---|---|
| Beta | 0.653 |
| Beta Downside | 0.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.44% |
| CAGR/Max DD | 0.84 |
EPS (Earnings per Share)
Revenue
Description: PLMR Palomar Holdings January 11, 2026
Palomar Holdings, Inc. (NASDAQ: PLMR) is a U.S.–based specialty insurer that underwrites property and casualty coverages for both individuals and businesses. Its product suite spans residential and commercial earthquake, inland-marine, Hawaii hurricane, flood, excess national property, and crop insurance, as well as assumed reinsurance and fronting arrangements. Distribution is handled through a mix of retail agents, wholesale brokers, program administrators, and carrier partnerships.
Key operating metrics from the most recent filing (2023) show a net written premium (NWP) of approximately $1.2 billion, representing a 9 % year-over-year increase, while the combined ratio hovered around 95 %, indicating underwriting profitability but leaving limited margin for loss-adjustment volatility. The companys exposure to natural-catastrophe risk is a primary driver of earnings variability, with the 2023 Atlantic hurricane season contributing roughly $15 million to loss reserves.
Sector-wide, specialty P&C insurers are currently benefiting from a hard reinsurance market and elevated interest rates, which boost investment income-a non-underwriting revenue source that accounted for about 18 % of PLMR’s total income in 2023. However, rising construction costs and inflationary pressures on repair expenses pose headwinds to loss ratios across the industry.
For a deeper dive into Palomar’s financial health and valuation dynamics, a quick look at ValueRay’s analyst toolkit can help you surface the most relevant data points.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 197.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.98 > 1.0 |
| NWC/Revenue: 143.2% < 20% (prev 45.40%; Δ 97.83% < -1%) |
| CFO/TA 0.12 > 3% & CFO 364.3m > Net Income 197.1m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 716.5 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.3m) vs 12m ago 0.43% < -2% |
| Gross Margin: 56.17% > 18% (prev 0.49%; Δ 5568 % > 0.5%) |
| Asset Turnover: 33.57% > 50% (prev 24.48%; Δ 9.08% > 0%) |
| Interest Coverage Ratio: 463.0 > 6 (EBITDA TTM 254.5m / Interest Expense TTM 391.0k) |
Altman Z'' 3.66
| A: 0.43 (Total Current Assets 1.25b - Total Current Liabilities 1.75m) / Total Assets 2.94b |
| B: 0.12 (Retained Earnings 365.8m / Total Assets 2.94b) |
| C: 0.07 (EBIT TTM 181.0m / Avg Total Assets 2.60b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 2.07b) |
| Altman-Z'' Score: 3.66 = AA |
Beneish M
| DSRI: none (Receivables none/700.9m, Revenue 873.7m/553.8m) |
| GMI: 0.87 (GM 56.17% / 48.65%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.58 (Revenue 873.7m / 553.8m) |
| TATA: -0.06 (NI 197.1m - CFO 364.3m) / TA 2.94b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of PLMR shares?
Over the past week, the price has changed by +4.39%, over one month by +2.83%, over three months by +2.82% and over the past year by +6.42%.
Is PLMR a buy, sell or hold?
- StrongBuy: 3
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PLMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 164.8 | 24.8% |
| Analysts Target Price | 164.8 | 24.8% |
PLMR Fundamental Data Overview February 17, 2026
P/S = 3.9994
P/B = 3.7187
Revenue TTM = 873.7m USD
EBIT TTM = 181.0m USD
EBITDA TTM = 254.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.50b USD (3.50b + (null Debt) - (null CCE))
Interest Coverage Ratio = 463.0 (Ebit TTM 181.0m / Interest Expense TTM 391.0k)
EV/FCF = 9.78x (Enterprise Value 3.50b / FCF TTM 358.3m)
FCF Yield = 10.23% (FCF TTM 358.3m / Enterprise Value 3.50b)
FCF Margin = 41.01% (FCF TTM 358.3m / Revenue TTM 873.7m)
Net Margin = 22.56% (Net Income TTM 197.1m / Revenue TTM 873.7m)
Gross Margin = 56.17% ((Revenue TTM 873.7m - Cost of Revenue TTM 382.9m) / Revenue TTM)
Gross Margin QoQ = 72.03% (prev 47.24%)
Tobins Q-Ratio = 1.19 (Enterprise Value 3.50b / Total Assets 2.94b)
Interest Expense / Debt = unknown (Interest Expense 87.0k / Debt none)
Taxrate = 22.70% (16.5m / 72.7m)
NOPAT = 139.9m (EBIT 181.0m * (1 - 22.70%))
Current Ratio = 716.5 (out of range, set to none) (Total Current Assets 1.25b / Total Current Liabilities 1.75m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 254.5m)
Debt / FCF = unknown (Net Debt none / FCF TTM 358.3m)
Total Stockholder Equity = 811.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.57% (Net Income 197.1m / Total Assets 2.94b)
RoE = 24.29% (Net Income TTM 197.1m / Total Stockholder Equity 811.2m)
RoCE = 6.15% (EBIT 181.0m / Capital Employed (Total Assets 2.94b - Current Liab 1.75m))
RoIC = 16.69% (NOPAT 139.9m / Invested Capital 838.6m)
WACC = 8.32% (E(3.50b)/V(3.50b) * Re(8.32%) + (debt-free company))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.98%
[DCF Debug] Terminal Value 80.23% ; FCFF base≈298.2m ; Y1≈367.8m ; Y5≈626.4m
Fair Price DCF = 374.8 (EV 9.94b - Net Debt 0.0 = Equity 9.94b / Shares 26.5m; r=8.32% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 89.05 | EPS CAGR: 37.42% | SUE: 1.46 | # QB: 10
Revenue Correlation: 97.54 | Revenue CAGR: 36.86% | SUE: 0.63 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.28 | Chg30d=+0.180 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=9.56 | Chg30d=+0.904 | Revisions Net=-1 | Growth EPS=+21.7% | Growth Revenue=+37.0%
EPS next Year (2027-12-31): EPS=10.79 | Chg30d=+0.959 | Revisions Net=+0 | Growth EPS=+12.8% | Growth Revenue=+22.4%